Indication

Neulasta® is a prescription medication used to help reduce the chance of infection due to a low white blood cell count, in people with certain types of cancer (non-myeloid), who receive anti-cancer medicines (chemotherapy) that can cause fever and low blood cell count.

Neulasta® is a prescription medication used to help reduce the chance of infection due to a low white blood cell count, in people with certain types of cancer (non-myeloid), who receive anti-cancer Read more medicines (chemotherapy) that can cause fever and low blood cell count. Close

Neulasta® is a prescription medication used to help reduce the chance of infection due to a low white blood cell count, Read more in people with certain types of cancer (non-myeloid), who receive anti-cancer medicines (chemotherapy) that can cause fever and low blood cell count. Close

You are now leaving Neulasta.com

The sponsors of this site are not responsible for content on the site you are about to enter.

You are going to a website that contains clinical information and was created specifically for healthcare professionals. If you are not a healthcare professional, and would like to return to the consumer site, please click CANCEL.

Onpro Kit

Neulasta® Onpro

Consider the possibility of fewer doctor visits*

Consider the possibility of fewer doctor visits with Neulasta® Onpro.*

Neulasta® Onpro is a kit that includes a co-packaged single dose of Neulasta® and a single-use On-body Injector, a small, lightweight delivery system applied to the skin during your chemo appointment. It’s designed to automatically administer Neulasta® the next day, so that you may not have to return to the doctor just for a shot of Neulasta®.*

Something you should know about strong chemotherapy.

While strong chemotherapy can help fight cancer, it can reduce your white blood cell count, weakening your immune system. A weakened immune system increases your risk of infection.

That’s where Neulasta® may help.

Neulasta® boosts your white blood cell count which strengthens your immune system and reduces your risk for infection. In a key study of 928 patients, when given once every chemo cycle, Neulasta® reduced the risk of infection from 17% in patients not treated with Neulasta® to 1% in patients treated with Neulasta®—a 94% decrease. Ask your doctor if Neulasta® and Neulasta® Onpro™ are right for you.

* If, for any reason, you believe you did not receive your full dose of Neulasta® or that your On-body Injector is not working correctly, immediately contact your healthcare provider
Delivered over 45 minutes, approximately 27 hours after activation

Watch the TV commercial for Neulasta® Onpro™

Starting Strong Chemo? Read about Neulasta® and Neulasta® Onpro

Download brochure

Already using Neulasta® Onpro? Read more about how it works

Download brochure

Things to know about Neulasta® Onpro™

  • Neulasta® Onpro™ can be used for every cycle of your strong chemotherapy
  • The Neulasta® Onpro™ kit includes a single dose of Neulasta® and a single-use On-body Injector
  • The On-body Injector for Neulasta® is designed to let you know when your dose should be complete and when it can be removed and discarded
  • The On-body Injector for Neulasta® is for adult patients only
  • The 24-hour Neulasta® Support line 1-844-MYNEULASTA (1-844-696-3852) is available to answer any questions about Neulasta® Onpro™
  • Your doctor or nurse will explain how Neulasta® Onpro™ works in greater detail

Talk to your doctor about Neulasta® before starting strong chemo

Ask these questions

How to take Neulasta®

There are two ways in which you may receive your Neulasta®—either Neulasta® Onpro™ or Neulasta® by manual injection. Talk with your doctor to determine which option is right for you. You should only receive a dose of Neulasta® on the day your doctor tells you. You should not receive your dose of Neulasta® any sooner than 24 hours after you finish each chemotherapy cycle.

If you are giving someone else Neulasta® by manual injection, it is important to know how to administer each dose. Please see the Neulasta® Patient Product Information to read How To Prepare and Give a Neulasta® Manual Injection.

Watch a video about Neulasta® Onpro™

See how Neulasta® Onpro™ is designed to automatically administer Neulasta® the day after chemotherapy.

Delivered approximately 27 hours after activation

Watch a video about Neulasta® Onpro™

See how Neulasta® Onpro™ is designed to automatically administer Neulasta® the day after chemotherapy.

How do I dispose of the On-body Injector for Neulasta®?

The On-body Injector for Neulasta®, part of the Neulasta® Onpro™ kit, must be properly disposed after use to avoid accidental needle stick. The Sharps Disposal Container Program is a free program to help you safely dispose of your On-body Injector for Neulasta® after use.

Sign up now

Important Safety Information

Who should not take Neulasta®?

Do not take Neulasta® if you have had a serious allergic reaction to Neulasta® (pegfilgrastim) or to NEUPOGEN® (filgrastim).

What should I tell my health care provider before taking Neulasta®? Tell your healthcare provider if you:

  • Have sickle cell trait or sickle cell disease
  • Have had severe skin reactions to acrylic adhesives
  • Are allergic to latex
  • Have problems with your kidneys
  • Have any other medical problems
  • Are pregnant or plan to become pregnant. It is not known if Neulasta® may harm your unborn baby.
  • Are breastfeeding or plan to breastfeed. It is not known if Neulasta® passes into your breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are possible serious side effects of Neulasta®?

  • Spleen Rupture. Your spleen may become enlarged and can rupture while taking Neulasta®. A ruptured spleen can cause death. Call your doctor right away if you have pain in the left upper stomach area or left shoulder tip area. This pain could mean your spleen is enlarged or ruptured.
  • A serious lung problem called Acute Respiratory Distress Syndrome (ARDS). Call your healthcare provider or get emergency medical help right away if you get any of these symptoms of ARDS: fever, shortness of breath, trouble breathing, or a fast rate of breathing.
  • Serious Allergic Reactions. Get emergency medical help right away if you get any of these symptoms of a serious allergic reaction with Neulasta®: shortness of breath, wheezing, dizziness, swelling around the mouth or eyes, fast pulse, sweating, and hives.

If you have an allergic reaction during the delivery of Neulasta®, remove the On-body Injector for Neulasta® by grabbing the edge of the adhesive pad and peeling off the On-body Injector. Get emergency medical help right away.

  • Sickle Cell Crises. Severe sickle cell crises, and sometimes death, can happen in people with sickle cell trait or disease who receive filgrastim, a medicine similar to Neulasta®.
  • Kidney injury (glomerulonephritis). Kidney injury has been seen in patients who received Neulasta®. You should notify your healthcare provider right away if you experience puffiness in your face or ankles, blood in your urine or brown colored urine or you notice you urinate less than usual.
  • Increased white blood cell count (leukocytosis). Your doctor will check your blood during treatment with Neulasta®.
  • Capillary Leak Syndrome. Neulasta® can cause fluid to leak from blood vessels into your body’s tissues. This condition is called "Capillary Leak Syndrome" (CLS). CLS can quickly cause you to have symptoms that may become life-threatening. Get emergency medical help right away if you develop any of the following symptoms:
    • swelling or puffiness and are urinating less often
    • trouble breathing
    • swelling of your stomach area (abdomen) and feeling of fullness
    • dizziness or feeling faint
    • a general feeling of tiredness

The most common side effect of Neulasta® is pain in the bones and in your arms and legs.

Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of Neulasta®. Call your doctor for medical advice about side effects. You may report negative side effects to the FDA at 1-800-FDA-1088.

For more information about Neulasta®, talk with your healthcare provider or pharmacist; go to www.neulasta.com, or call 1-844-696-3852 (1-844-MYNEULASTA).

Please see Neulasta® Patient Information.

Important Safety Information
Who should not take Neulasta®?
Do not take Neulasta® if you have had a serious allergic reaction to Neulasta® (pegfilgrastim) or to NEUPOGEN® (filgrastim).
What should I tell my health care provider before taking Neulasta®? Tell your healthcare provider if you:
• Have sickle cell trait or sickle cell disease

See More Close